AXGN logo

Axogen, Inc. (AXGN)

Profile

Full Name

Axogen, Inc.

Ticker

NASDAQ: AXGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

December 17, 1986

Indexes

Not included

Website

http://www.axogeninc.com

Employees

451

Key Details

Price

$13.37(+1.21%)

Market cap

$608.92M(Small cap)

Last Dividend

$1.00

TTM Dividend yield

-

Annual revenue

$187.34M(+17.81% YoY)

Annual EPS

-$0.23(+54.90% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $13.37
    AXGN price is $13.37

    30-Day Relative Volume

    0.88
    AXGN 30-day relative volume is 0.88

    Price Performance

    Price Most recent change

    +1.21%
    AXGN price was up +1.21% on Jul 25, 2025

    Price YTD change

    -18.87%
    AXGN price is down -18.87% since January 1st

    Price 1-year change

    +43.3%
    AXGN price is up +43.3% year-on-year

    Price 3-year change

    +44.38%
    AXGN price is up +44.38% over the past 3 years

    Price Range

    Price All-time high

    $56.85
    AXGN price is currently -76.48% below its historical high of $56.85

    Price 3-year low

    $3.45
    AXGN price is currently +287.54% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $608.92M
    AXGN market capitalization is $608.92 million

    Market cap 3-year change

    +56.07%
    AXGN market capitalization is up +56.07% over the past 3 years

    Market cap All-time high

    $2.14B
    AXGN market capitalization is currently -71.57% below its historical high of $2.14 billion

    Market cap sector rank

    68.1%
    AXGN market capitalization is higher than 68.1% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.92%
    AXGN shares outstanding is up +3.92% year-on-year

    Shares Outstanding 3-Year Change

    +8.09%
    AXGN shares outstanding is up +8.09% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.93
    AXGN beta is 0.93

    200-day SMA

    $14.80
    AXGN price is currently -9.66% below its 200-day simple moving average

    50-day SMA

    $11.13
    AXGN price is currently +20.10% above its 50-day simple moving average

    RSI

    68.90
    AXGN 14-day relative strength index is 68.90

    Volume

    0.88
    AXGN 30-day relative volume is 0.88

    ATR

    $0.64
    AXGN average true range is $0.64

    10-day Historical Volatility

    62.37%
    AXGN 10-day historical volatility is 62.37%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $1.00
    AXGN last dividend was $1.00 per share, with an ex-dividend date of January 27, 2010

    Next Dividend

    -
    AXGN next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    AXGN annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    AXGN annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    AXGN annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    AXGN annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    AXGN annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    AXGN annual dividend yield is unknown

    Other

    Payout ratio

    -
    AXGN annual payout ratio value is unknown

    Dividends paid

    -
    AXGN annual dividends paid value is unknown

    Free cash flow

    $11.00K
    AXGN annual free cash flow is $11.00 thousand

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $187.34M
    AXGN annual revenue is $187.34 million

    Revenue Analysts estimate

    $216.18M
    AXGN annual revenue is currently -13.34% lower than the consensus analysts' forecast

    Revenue 1-year change

    +17.81%
    AXGN annual revenue is up +17.81% year-on-year

    Revenue Sector rank

    62.86%
    AXGN annual revenue is higher than 62.86% of companies in Healthcare sector

    EPS

    EPS

    -$0.23
    AXGN annual earnings per share is -$0.23

    EPS Analysts estimate

    $0.20
    AXGN annual earnings per share is currently -212.75% lower than the consensus analysts' forecast

    EPS 1-year change

    +54.9%
    AXGN annual earnings per share is up +54.9% year-on-year

    EPS Sector rank

    74.94%
    AXGN annual earnings per share is higher than 74.94% of companies in Healthcare sector

    Profit

    Gross profit

    $141.98M
    AXGN annual gross profit is $141.98 million

    Gross margin

    75.79%
    AXGN annual gross profit margin is 75.79%

    Operating profit

    -$3.29M
    AXGN annual operating income is -$3.29 million

    Operating margin

    -1.75%
    AXGN annual operating profit margin is -1.75%

    Net income

    -$9.96M
    AXGN annual net profit is -$9.96 million

    Net margin

    -5.32%
    AXGN annual net profit margin is -5.32%

    Expenses

    Total expenses

    $190.63M
    AXGN annual total expenses is $190.63 million

    Operating expenses

    $145.26M
    AXGN annual total operating expenses is $145.26 million

    Cost of goods sold

    $45.36M
    AXGN annual cost of goods sold is $45.36 million

    Selling, general & administrative expenses

    $117.50M
    AXGN annual SGA is $117.50 million

    Depreciation and amortization

    $7.84M
    AXGN annual depreciation & amortization is $7.84 million

    Interest expense

    $8.21M
    AXGN annual interest expense is $8.21 million

    Income tax

    -
    AXGN annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$1.76M
    AXGN annual earnings before interest & taxes is -$1.76 million

    EBITDA

    $6.08M
    AXGN annual EBITDA is $6.08 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $203.73M
    AXGN annual total assets is $203.73 million

    Non current assets

    $104.51M
    AXGN annual long term assets is $104.51 million

    Current assets

    $99.22M
    AXGN annual total current assets is $99.22 million

    Cash and cash equivalents

    $27.55M
    AXGN annual cash & cash equivalents is $27.55 million

    Accounts receivable

    $24.11M
    AXGN annual accounts receivable is $24.11 million

    Inventory

    $33.18M
    AXGN annual inventory is $33.18 million

    Liabilities

    Total liabilities

    $99.82M
    AXGN annual total liabilities is $99.82 million

    Long term liabilities

    $69.21M
    AXGN annual total long term liabilities is $69.21 million

    Current liabilities

    $30.61M
    AXGN annual total current liabilities is $30.61 million

    Accounts payable

    $8.01M
    AXGN annual accounts payable is $8.01 million

    Debt

    Total debt

    $68.69M
    AXGN annual total debt is $68.69 million

    Total debt 1-year change

    -0.87%
    AXGN annual total debt is down -0.87% year-on-year

    Long term debt

    $66.72M
    AXGN annual long term debt is $66.72 million

    Short term debt

    $1.97M
    AXGN annual short term debt is $1.97 million

    Equity & Capital

    Shareholders equity

    $103.91M
    AXGN annual stockholders equity is $103.91 million

    Book value

    $103.91M
    AXGN annual book value is $103.91 million

    Retained earnings

    -$291.26M
    AXGN annual retained earnings is -$291.26 million

    Working capital

    $68.61M
    AXGN annual working capital is $68.61 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $4.54M
    AXGN annual cash flow from operations is $4.54 million

    Cash from operations 1-year change

    +179.34%
    AXGN annual cash flow from operations is up +179.34% year-on-year

    Cash from investing

    -$10.30M
    AXGN annual cash flow from investing activities is -$10.30 million

    Cash from investing 1-year change

    -153.48%
    AXGN annual cash flow from investing activities is down -153.48% year-on-year

    Cash from financing

    $2.29M
    AXGN annual cash flow from financing activities is $2.29 million

    Cash from financing 1-year change

    +17.2%
    AXGN annual cash flow from financing activities is up +17.2% year-on-year

    CAPEX

    CAPEX

    $4.52M
    AXGN annual capital expenditures is $4.52 million

    CAPEX 1-year change

    -69.67%
    AXGN annual capital expenditures is down -69.67% year-on-year

    Free Cash Flow

    Free cash flow

    $11.00K
    AXGN annual free cash flow is $11.00 thousand

    Free cash flow 1-year change

    +100.05%
    AXGN annual free cash flow is up +100.05% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    75.79%
    AXGN annual gross profit margin is 75.79%

    Operating margin

    -1.75%
    AXGN annual operating profit margin is -1.75%

    Net margin

    -5.32%
    AXGN annual net profit margin is -5.32%

    ROA & ROE

    ROA

    -4.98%
    AXGN annual return on assets is -4.98%

    ROE

    -9.99%
    AXGN annual return on equity is -9.99%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AXGN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AXGN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    5.78
    AXGN price to book ratio is 5.78

    PB ratio Sector rank

    81.89%
    AXGN price to book ratio is higher than 81.89% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.13
    AXGN price to sales ratio is 3.13

    PS ratio Sector rank

    50.13%
    AXGN price to sales ratio is higher than 50.13% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $659.27M
    AXGN enterprise value is $659.27 million

    Enterprise value Sector rank

    68.56%
    AXGN enterprise value is higher than 68.56% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    75.02
    AXGN EV/EBITDA is 75.02

    EV/EBITDA Sector rank

    98.24%
    AXGN EV/EBITDA is higher than 98.24% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.24
    AXGN annual current ratio is 3.24

    Quick ratio

    2.16
    AXGN annual quick ratio is 2.16

    Leverage

    Debt to equity

    0.46
    AXGN annual debt to equity ratio is 0.46

    Interest coverage ratio

    -0.21
    AXGN annual interest coverage ratio is -0.21

    Risk & Stability

    Piotroski F-Score

    5
    AXGN piotroski f-score is 5

    Altman Z-Score

    2.95
    AXGN altman z-score is 2.95

    Analyst ratings

    Recent major analysts updates

    May 13, 25 Canaccord Genuity
    Buy
    Mar 17, 25 Lake Street
    Buy
    Mar 5, 25 Citizens Capital Markets
    Market Outperform
    Mar 5, 25 Cantor Fitzgerald
    Overweight
    Feb 26, 25 Citizens Capital Markets
    Market Outperform
    Feb 26, 25 Canaccord Genuity
    Buy
    Feb 3, 25 Canaccord Genuity
    Buy
    Aug 9, 24 JMP Securities
    Market Outperform
    Jul 1, 24 Raymond James
    Outperform
    Jun 20, 24 Canaccord Genuity
    Buy

    Institutional Ownership

    Screeners with AXGN included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Axogen, Inc.?
    • Does Axogen, Inc. pay dividends?
    • What sector is Axogen, Inc. in?
    • What industry is Axogen, Inc. in?
    • What country is Axogen, Inc. based in?
    • When did Axogen, Inc. go public?
    • Is Axogen, Inc. in the S&P 500?
    • Is Axogen, Inc. in the NASDAQ 100?
    • Is Axogen, Inc. in the Dow Jones?
    • When was Axogen, Inc.'s last earnings report?
    • When does Axogen, Inc. report earnings?

    What is the ticker symbol for Axogen, Inc.?

    The ticker symbol for Axogen, Inc. is NASDAQ:AXGN

    Does Axogen, Inc. pay dividends?

    No, Axogen, Inc. does not pay dividends

    What sector is Axogen, Inc. in?

    Axogen, Inc. is in the Healthcare sector

    What industry is Axogen, Inc. in?

    Axogen, Inc. is in the Medical Devices industry

    What country is Axogen, Inc. based in?

    Axogen, Inc. is headquartered in United States

    When did Axogen, Inc. go public?

    Axogen, Inc.'s initial public offering (IPO) was on December 17, 1986

    Is Axogen, Inc. in the S&P 500?

    No, Axogen, Inc. is not included in the S&P 500 index

    Is Axogen, Inc. in the NASDAQ 100?

    No, Axogen, Inc. is not included in the NASDAQ 100 index

    Is Axogen, Inc. in the Dow Jones?

    No, Axogen, Inc. is not included in the Dow Jones index

    When was Axogen, Inc.'s last earnings report?

    Axogen, Inc.'s most recent earnings report was on May 8, 2025

    When does Axogen, Inc. report earnings?

    The next expected earnings date for Axogen, Inc. is August 5, 2025
    On this page